Literature DB >> 14759723

PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence.

Christine Solbach1, Marc Roller, Christian Fellbaum, Maria Nicoletti, Manfred Kaufmann.   

Abstract

The proto-oncogene pituitary tumor-transforming gene (PTTG) is described as abundantly overexpressed in a variety of neoplasms and cancer cell lines. We analyzed PTTG mRNA expression in 72 tumor samples derived from primary tumors of patients suffering from breast cancer and in unaffected breast epithelium, checking for correlations between expression levels and standard clinico-pathological parameters over a 5-year observation period. We found a direct correlation between PTTG mRNA overexpression and lymph node infiltration. Furthermore, overexpression of this gene in tumors correlated with a higher degree of tumor recurrence within the subsequent observation period. Taken together, these results demonstrate that determination of PTTG expression in primary tumors of the breast is a powerful tool for the assessment of potential tumor aggressiveness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14759723     DOI: 10.1016/j.breast.2003.09.008

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  41 in total

1.  Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression.

Authors:  Zhen-Zhong Feng; Jia-Wei Chen; Zhao-Rui Yang; Guang-Zhong Lu; Zhao-Gen Cai
Journal:  Med Oncol       Date:  2010-12-22       Impact factor: 3.064

2.  Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins.

Authors:  Sudhakar Chintharlapalli; Sabitha Papineni; Syng-Ook Lee; Ping Lei; Un Ho Jin; Steven I Sherman; Libero Santarpia; Stephen Safe
Journal:  Mol Carcinog       Date:  2011-01-25       Impact factor: 4.784

Review 3.  The emerging role of pituitary tumor transforming gene in tumorigenesis.

Authors:  Jacob Tfelt-Hansen; Deepthi Kanuparthi; Naibedya Chattopadhyay
Journal:  Clin Med Res       Date:  2006-06

4.  Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis.

Authors:  Kunpeng Ma; Limin Ma; Zhaocheng Jian
Journal:  Oncol Lett       Date:  2018-05-18       Impact factor: 2.967

5.  Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.

Authors:  Mi-die Xu; Lei Dong; Peng Qi; Wei-wei Weng; Xiao-han Shen; Shu-juan Ni; Dan Huang; Cong Tan; Wei-qi Sheng; Xiao-yan Zhou; Xiang Du
Journal:  Gastric Cancer       Date:  2015-01-28       Impact factor: 7.370

6.  MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Weining Wu; Er Nie; Xu Zhou; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Tetsuo Ito; Yutaka Shimada; Takatsugu Kan; Stefan David; Yulan Cheng; Yuriko Mori; Rachana Agarwal; Bogdan Paun; Zhe Jin; Alexandru Olaru; James P Hamilton; Jian Yang; John M Abraham; Stephen J Meltzer; Fumiaki Sato
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

8.  Breast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signatures.

Authors:  M C Abba; E Lacunza; M Butti; C M Aldaz
Journal:  Biomark Insights       Date:  2010-10-27

9.  Securin promotes the identification of favourable outcome in invasive breast cancer.

Authors:  K Talvinen; H Karra; S Hurme; M Nykänen; A Nieminen; J Anttinen; T Kuopio; P Kronqvist
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

10.  Effect of PTTG on endogenous gene expression in HEK 293 cells.

Authors:  Siva K Panguluri; Sham S Kakar
Journal:  BMC Genomics       Date:  2009-12-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.